Innovent Biologics

Performance

About Innovent Biologics

Innovent Biologics is a biopharmaceutical company focused on the development and commercialization of innovative therapies, primarily in oncology and autoimmune diseases. Headquartered in China, it develops monoclonal antibodies and other biologics, with a broad product pipeline and collaboration strategy to advance cancer and immune-mediated disease treatments across Asia and globally. The company emphasizes integrated discovery, development, manufacturing, and partner programs to bring therapies to market. Its Chinese language site highlights research areas, product lines, and corporate governance, indicating an emphasis on global collaboration and patient-centric innovation.